—

CellaVision AB (CEVI.ST) — Technical state

As of 2026-11-13 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 61 out of 100 (momentum 96 · quality 72 · valuation 27), as of 2026-11-17.
  • Signal: Stochastic turned down — Its stochastic crossed down from overbought (%K 92.9 under %D 93.1) today — momentum is cooling. (as of 2026-11-13)
  • Trend: CellaVision AB trades 16.8% above its 50-day and 35.5% above its 200-day moving average. (as of 2026-11-13)
  • Index seat: Euro-AI 50

CellaVision designs microscopy instruments, software and reagents that automate the reading of blood and body-fluid samples in laboratories. Its systems analyse blood cell differentials, bone marrow aspirates and body fluid preparations, replacing manual microscope review with digital image capture and software classification.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the CEVI.ST overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Stochastic turned down

Its stochastic crossed down from overbought (%K 92.9 under %D 93.1) today — momentum is cooling.

The moving-average stack

FAQ · from the current data · as of 2026-11-13

Quick answers

What is the current Closelooknet signal on CEVI.ST?

Stochastic turned down — Its stochastic crossed down from overbought (%K 92.9 under %D 93.1) today — momentum is cooling. As of 2026-11-13; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is CEVI.ST above its 50-day and 200-day moving averages?

As of 2026-11-13, CellaVision AB trades +16.8% above its 50-day and +35.5% above its 200-day average, with the 20-day +9.3% away.

How far is CEVI.ST from its 52-week high?

1.2% below the 52-week high and 73.4% above the 52-week low, as of 2026-11-13.

Related in the Closelooknet universe

same Closelooknet index seat first, then Medical Devices. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.